Abeona Therapeutics Inc vs Intel Corp — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Intel Corp trades at $99 (market cap $492.85B). The key difference: Intel Corp is far larger — about 1170.1× Abeona Therapeutics Inc's market cap, and Intel Corp pays a 2.24% dividend while Abeona Therapeutics Inc pays none. Which is the better fit depends on your goals.
| ABEO | INTC | |
|---|---|---|
Market Cap | $421.19M | $492.85B |
Sector | Health | Technology |
52-Week High | $7.45 | $140.94 |
52-Week Low | $4.17 | $21.81 |
Enterprise Value | $276.10M | $513.66B |
Volume | — | 43,552,012 |
Dividend Yield | — | 2.24% |
Trailing returns across standard periods
Latest headlines on both assets
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.
Read more on INTC →